First-in-Class vs Me-Too Launch Differences and the Role of Content, Hyperpersonalization, and Technology with Frank Dolan, Founder and CEO of ARSENAL

Pharma Launch Secrets

Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-Like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide

In this episode, Bozidar is joined by Frank Dolan, Founder and CEO of ARSENAL.

They cover:

• How are first-in-class launches distinct from me-too launches?
• Why is it so hard to access HCPs and launch products successfully?
• What are the opportunities for 1st-time launchers to have successful launches despite reduced access to HCPs?
• Will pharma encourage or discourage peer-to-peer scientific exchange online?

Subscribe here:

• Apple: https://apple.co/3micGmF
• Google Podcasts: https://bit.ly/3PUds6T
• Spotify: https://spoti.fi/3M78XCC
• RSS: https://bit.ly/3wTksIm

And connect with the host and guest here:

• Bozidar Jovicevic: https://www.linkedin.com/in/bjovicevic
• Evermed: https://evermedtv.com
• Frank Dolan: https://www.linkedin.com/in/frankfdolan/
• ARSENAL: https://arsenal-advisors.com/

About The Show:

“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.

Check out our three most downloaded episodes:

• Omnichannel and CDP (Customer Data Platforms): What Every Pharma Marketer Needs To Know About Using Data To Enable Seamless Customer Experience, Drive Engagement, And Lift Rx
• Greatest Hits: A Look Back on Five of the Best Pharma Launch Secrets Episodes
• Launch Planning in a Digital-First Reality: How Can a Traditional “Reach and Frequency” Model Be Adapted to an Omnichannel Future?
  

If you are interested in joining Pharma Launch Secrets as a guest, please visit this link: start.evermedtv.com/podcast-apply/